Chlamydia (CT) and gonorrhea (GC) are the two most commonly reported notifiable diseases in the United States and case reports have been increasing in recent years. New technology may soon allow individuals to test themselves for CT and GC, either at home, or in a clinic or physician’s office. This presents both challenges and opportunities for public health practice. This presentation will cover a range of implications of point of care and home testing, including for testing, for treatment of index patients and partners, for surveillance, and for reaching priority populations. Data on acceptability of such tests among priority populations, including men who have sex with men and young adults, as well as among physicians from a variety of disciplines, will also be presented.

Disclosure No significant relationships.